Second-Generation Pharmacological Chaperones: Beyond Inhibitors.

Abstract excerpt

Protein misfolding induced by missense mutations is the source of hundreds of conformational diseases. The cell quality control may eliminate nascent misfolded proteins, such as enzymes, and a pathological loss-of-function may result from their early degradation. Since the proof of concept in the 2000s, the bioinspired pharmacological chaperone therapy became a relevant low-molecular-weight compound strategy...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Enzyme Activators
• Share to Enzyme Inhibitors
• Share to Molecular Chaperones